Smith & Nephew SNATS (NYSE:SNN) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Smith & Nephew SNATS (NYSE:SNN) from a hold rating to a buy rating in a research note issued to investors on Monday morning.

Several other equities analysts also recently commented on SNN. The Goldman Sachs Group reissued a “buy” rating on shares of Smith & Nephew SNATS in a research note on Monday, May 25th. Weiss Ratings cut shares of Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, June 11th. Zacks Research downgraded shares of Smith & Nephew SNATS from a “hold” rating to a “strong sell” rating in a report on Friday, August 7th. Kepler Capital Markets cut Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research note on Thursday, June 4th. Finally, Sanford C. Bernstein set a $31.85 price target on Smith & Nephew SNATS in a research note on Monday, May 11th. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Smith & Nephew SNATS presently has a consensus rating of “Hold” and an average target price of $30.93.

Smith & Nephew SNATS Stock Performance

SNN stock opened at $29.32 on Monday. The firm has a 50-day moving average price of $30.26 and a 200-day moving average price of $31.74. Smith & Nephew SNATS has a 12 month low of $28.56 and a 12 month high of $38.79. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11.

Smith & Nephew SNATS Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 2nd will be issued a $0.312 dividend. This represents a yield of 205.0%. The ex-dividend date is Friday, October 2nd.

Institutional Investors Weigh In On Smith & Nephew SNATS

A number of institutional investors have recently added to or reduced their stakes in SNN. Plan A Wealth LLC increased its position in Smith & Nephew SNATS by 16.5% in the 2nd quarter. Plan A Wealth LLC now owns 8,607 shares of the medical equipment provider’s stock valued at $248,000 after acquiring an additional 1,221 shares during the period. Concurrent Investment Advisors LLC acquired a new position in shares of Smith & Nephew SNATS during the second quarter worth $313,000. Rakuten Investment Management Inc. acquired a new position in shares of Smith & Nephew SNATS during the second quarter worth $732,000. Empowered Funds LLC bought a new stake in shares of Smith & Nephew SNATS in the second quarter worth $824,000. Finally, United Capital Financial Advisors LLC bought a new stake in shares of Smith & Nephew SNATS in the second quarter worth $302,000. 25.64% of the stock is owned by institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.